These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 17595769)

  • 21. 2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors.
    Beckers T; Reissmann T; Schmidt M; Burger AM; Fiebig HH; Vanhoefer U; Pongratz H; Hufsky H; Hockemeyer J; Frieser M; Mahboobi S
    Cancer Res; 2002 Jun; 62(11):3113-9. PubMed ID: 12036922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. YHHU0895, a novel synthetic small-molecule microtubule-destabilizing agent, effectively overcomes P-glycoprotein-mediated tumor multidrug resistance.
    Zhao H; Quan H; Xie C; Xu Y; Xie F; Hu Y; Lou L
    Cancer Lett; 2012 Jan; 314(1):54-62. PubMed ID: 21982683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity.
    Pryor DE; O'Brate A; Bilcer G; Díaz JF; Wang Y; Wang Y; Kabaki M; Jung MK; Andreu JM; Ghosh AK; Giannakakou P; Hamel E
    Biochemistry; 2002 Jul; 41(29):9109-15. PubMed ID: 12119025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Total synthesis of the microtubule stabilizing antitumor agent laulimalide and some nonnatural analogues: the power of Sharpless' asymmetric epoxidation.
    Ahmed A; Hoegenauer EK; Enev VS; Hanbauer M; Kaehlig H; Ohler E; Mulzer J
    J Org Chem; 2003 Apr; 68(8):3026-42. PubMed ID: 12688769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
    Edler MC; Buey RM; Gussio R; Marcus AI; Vanderwal CD; Sorensen EJ; Díaz JF; Giannakakou P; Hamel E
    Biochemistry; 2005 Aug; 44(34):11525-38. PubMed ID: 16114889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines.
    Gaitanos TN; Buey RM; Díaz JF; Northcote PT; Teesdale-Spittle P; Andreu JM; Miller JH
    Cancer Res; 2004 Aug; 64(15):5063-7. PubMed ID: 15289305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microtubule-stabilizing activity of zampanolide, a potent macrolide isolated from the Tongan marine sponge Cacospongia mycofijiensis.
    Field JJ; Singh AJ; Kanakkanthara A; Halafihi T; Northcote PT; Miller JH
    J Med Chem; 2009 Nov; 52(22):7328-32. PubMed ID: 19877653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Function-oriented synthesis, step economy, and drug design.
    Wender PA; Verma VA; Paxton TJ; Pillow TH
    Acc Chem Res; 2008 Jan; 41(1):40-9. PubMed ID: 18159936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Total synthesis and biological evaluation of 11-desmethyllaulimalide, a highly potent simplified laulimalide analogue.
    Wender PA; Hilinski MK; Soldermann N; Mooberry SL
    Org Lett; 2006 Mar; 8(7):1507-10. PubMed ID: 16562928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. R-253 disrupts microtubule networks in multiple tumor cell lines.
    Gururaja TL; Goff D; Kinoshita T; Goldstein E; Yung S; McLaughlin J; Pali E; Huang J; Singh R; Daniel-Issakani S; Hitoshi Y; Cooper RD; Payan DG
    Clin Cancer Res; 2006 Jun; 12(12):3831-42. PubMed ID: 16778111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic cure against human tumor xenografts in nude mice by a microtubule stabilization agent, fludelone, via parenteral or oral route.
    Chou TC; Dong H; Zhang X; Tong WP; Danishefsky SJ
    Cancer Res; 2005 Oct; 65(20):9445-54. PubMed ID: 16230408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol).
    Long BH; Carboni JM; Wasserman AJ; Cornell LA; Casazza AM; Jensen PR; Lindel T; Fenical W; Fairchild CR
    Cancer Res; 1998 Mar; 58(6):1111-5. PubMed ID: 9515790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of 10,11-dihydrodictyostatin, a potent analogue of the marine anticancer agent dictyostatin.
    Paterson I; Gardner NM; Poullennec KG; Wright AE
    J Nat Prod; 2008 Mar; 71(3):364-9. PubMed ID: 18081257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New potential anticancer agents based on the anthranilic acid scaffold: synthesis and evaluation of biological activity.
    Congiu C; Cocco MT; Lilliu V; Onnis V
    J Med Chem; 2005 Dec; 48(26):8245-52. PubMed ID: 16366606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The laulimalide family: total synthesis and biological evaluation of neolaulimalide, isolaulimalide, laulimalide and a nonnatural analogue.
    Gollner A; Altmann KH; Gertsch J; Mulzer J
    Chemistry; 2009 Jun; 15(24):5979-97. PubMed ID: 19402092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved cellular pharmacokinetics and pharmacodynamics underlie the wide anticancer activity of sagopilone.
    Hoffmann J; Vitale I; Buchmann B; Galluzzi L; Schwede W; Senovilla L; Skuballa W; Vivet S; Lichtner RB; Vicencio JM; Panaretakis T; Siemeister G; Lage H; Nanty L; Hammer S; Mittelstaedt K; Winsel S; Eschenbrenner J; Castedo M; Demarche C; Klar U; Kroemer G
    Cancer Res; 2008 Jul; 68(13):5301-8. PubMed ID: 18593931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
    Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
    Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 7-Diethylamino-3(2'-benzoxazolyl)-coumarin is a novel microtubule inhibitor with antimitotic activity in multidrug resistant cancer cells.
    Kim SN; Kim NH; Park YS; Kim H; Lee S; Wang Q; Kim YK
    Biochem Pharmacol; 2009 Jun; 77(12):1773-9. PubMed ID: 19428332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.